A 10-year-old girl who has been battling leukemia for more than four years has become the first person in Taiwan to be successfully treated with a new form of immunotherapy, doctors at National Taiwan University Hospital (NTUH) said yesterday.
The child, identified only as Ting-ting (亭亭), was diagnosed with pediatric B-cell acute lymphoblastic leukemia at the age of six and was initially receiving targeted chemotherapy, her doctors told a news conference.
When her leukemia recurred last year, doctors recommended the CD19 chimeric antigen receptor (CAR) T-cell therapy — a immunotherapy treatment that was introduced in the past decade and had never previously been used successfully to treat a person with leukemia in Taiwan.
Photo: Chiu Chih-jou, Taipei Times
After an infusion of CD19 CAR T-cells in April, Ting-ting’s cancer went into complete remission, the doctors said, adding that she was recently able to spend her 10th birthday at home with her family.
CAR T therapies became prominent in 2012, when they were successfully used in a clinical trial to treat Emily Whitehead, a six-year-old American girl who had been diagnosed with leukemia.
In such therapies, immune cells called T-cells are taken from a patient’s blood and modified by adding a gene for a CAR, which helps them attach to the specific cancer cell antigen. They are then put back in the patient.
Ting-ting’s mother recalled the difficulty she had in explaining the cancer diagnosis to such a young child, telling the news conference that she eventually told her daughter it was “like having a cold” and would get better if she took her medicine.
She thanked her daughter’s medical team for discussing with her the option of CAR T-cell therapy, which she said allowed them to begin the treatment as soon as Ting-ting’s cancer recurred.
Cancer is the second-leading cause of death among children in Taiwan and leukemia accounts for a significant proportion, said Lee Wang-tso (李旺祚), director of NTUH’s Department of Pediatrics.
In the past, the options for treating pediatric leukemia have been limited mainly to chemotherapy, which can cause adverse reactions, and bone marrow transplants, which are difficult to arrange and sometimes require the patient to take immunosuppressant drugs indefinitely, Lee said.
Jou Shiann-tang (周獻堂), a doctor in the hospital’s Department of Hematology and Oncology, said that about 500 new pediatric leukemia cases are diagnosed in Taiwan each year.
About one-quarter of them are acute lymphoblastic leukemia and about 15 percent of such patients have adverse reactions to treatment or the cancer recurs, Jou said.
Ting-ting’s parents said that the CD19 CAR T-cell therapy has the potential to help other children.
However, the treatment is not covered by the National Health Insurance, which meant that they had to sell their home to pay the NT$10 million (US$334,571) it cost.
The National Health Insurance Administration is reviewing whether to cover such treatments in the future, the hospital said.
Actor Darren Wang (王大陸) was sentenced to six months in prison, commutable to a fine, by the New Taipei District Court today for contravening the Personal Data Protection Act (個人資料保護法) in a case linked to an alleged draft-dodging scheme. Wang allegedly paid NT$3.6 million (US$114,380) to an illegal group to help him evade mandatory military service through falsified medical documents, prosecutors said. He transferred the funds to Chen Chih-ming (陳志明), the alleged mastermind of a draft-evasion ring, although he lost contact with him as he was already in detention on fraud charges, they said. Chen is accused of helping a
SECURITY: Starlink owner Elon Musk has taken pro-Beijing positions, and allowing pro-China companies to control Taiwan’s critical infrastructure is risky, a legislator said Starlink was reluctant to offer services in Taiwan because of the nation’s extremely high penetration rates in 4G and 5G services, the Ministry of Digital Affairs said yesterday. The ministry made the comments at a meeting of the legislature’s Transportation Committee, which reviewed amendments to Article 36 of the Telecommunications Management Act (電信管理法). Article 36 bans foreigners from holding more than 49 percent of shares in public telecommunications networks, while shares foreigners directly and indirectly hold are also capped at 60 percent of the total, unless specified otherwise by law. The amendments, sponsored by Chinese Nationalist Party (KMT) Legislator Ko
‘SAME OLD TRICK’: Even if Beijing resumes individual travel to Taiwan, it would only benefit Chinese tourism companies, the Economic Democracy Union convener said China’s 10 new “incentives” are “sugar-coated poison,” an official said yesterday, adding that Taiwanese businesses see them clearly for what they are, but that Beijing would inevitably find some local collaborators to try to drums up support. The official, speaking on condition of anonymity, made the remark ahead of a news conference the General Chamber of Commerce is to hold today. The event, titled “Industry Perspectives on China’s Recent Pro-Taiwan Policies,” is expected to include representatives from industry associations — such as those in travel, hotels, food and agriculture — to request the government cooperate with China’s new measures, people familiar with
The eastern extension of the Taipei MRT Red Line could begin operations as early as late June, the Taipei Department of Rapid Transit Systems said yesterday. Taipei Rapid Transit Corp said it is considering offering one month of free rides on the new section to mark its opening. Construction progress on the 1.4km extension, which is to run from the current terminal Xiangshan Station to a new eastern terminal, Guangci/Fengtian Temple Station, was 90.6 percent complete by the end of last month, the department said in a report to the Taipei City Council's Transportation Committee. While construction began in October 2016 with an
RSS